Effects of One-to-one Service on the Continuation and Satisfaction of Contraceptive Use.
NCT ID: NCT05362019
Last Updated: 2022-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
400 participants
INTERVENTIONAL
2022-05-31
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
NCT02021097
A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.
NCT06188026
A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant
NCT06461039
A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception
NCT04143659
A Study of Efficacy and Safety With the Transdermal Contraceptive System.
NCT00236769
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention group
A mobile phone based "service system" developed by the research group will be used to provide one-to-one service for the intervention group.
Compound Norethisterone Enanthate Injection
Combined injectable contraceptive use
One-to-one Service
A mobile phone based "service system" will be used to pushing contraceptive knowledges, reminding injection, providing consultation on adverse reactions and ect.
control group
Routine family planning services will be provided to the control group.
Compound Norethisterone Enanthate Injection
Combined injectable contraceptive use
Family Planning Service
routine family planning service and contraceptive service.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Compound Norethisterone Enanthate Injection
Combined injectable contraceptive use
One-to-one Service
A mobile phone based "service system" will be used to pushing contraceptive knowledges, reminding injection, providing consultation on adverse reactions and ect.
Family Planning Service
routine family planning service and contraceptive service.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy Volunteers;
* More than 6 months after delivery and without lactation;
* No fertility intention within 6 months;
* Normal menstruation;
* No contraindications to the use of compound contraceptive methods;
* Had not used hormonal contraception in the previous three months;
* Understand the content and requirements of the project, be willing to cooperate, and have signed the informed consent form;
* Have a certian education level, and be able to use the special sanitary napkins to record menstrual volume and menstrual card.
Exclusion Criteria
* Previous or current thrombotic disease;
* Malignant tumor of uterine organ;
* Unable to communicate normally due to disability or mental or intellectual impairment.
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Research Institute for Family Planning, China
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kaiyan Pei
Role: PRINCIPAL_INVESTIGATOR
National Research Institute for Family Planning, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qinghai People's Hospital
Xining, Qinghai, China
Qinghai Red Cross Hospital
Xining, Qinghai, China
Tianjin Central Hospital of Gynecology Obstetrics
Tianjin, Tianjin Municipality, China
Tianjin Dongli hospital
Tianjin, Tianjin Municipality, China
Tianjin Jinnan hospital
Tianjin, Tianjin Municipality, China
Tianjin Medical University second hospital
Tianjin, Tianjin Municipality, China
Yunnan Xishuangbanna maternal and Child Health Hospital
Xishuangbanna Dai Autonomous Prefecture, Yunnan, China
Yunnan Xishuangbanna people's Hospital
Xishuangbanna Dai Autonomous Prefecture, Yunnan, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Donyue Wu
Role: primary
Ying Lou
Role: primary
Hua Yang
Role: primary
Yan Wang
Role: primary
Shaoxia Liu
Role: primary
Jianmei Wang
Role: primary
Meixiu Tan
Role: primary
Juan Peng
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021HX019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.